XELOX stop-and-go trial:A phase 2 study of 1st line chemotherapy for unresectable or recurrent colorectal cancer.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2620630
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: XELOX therapy 6 courses, followed by XELODA 6 courses, then XELOX
Primary outcome(s): Progression free survival
Study Design: Single arm Non-randomized
创建时间：
2010-05-15
